Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health claims comment deadline

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association requests a 60-day extension of the comment period for FDA's advance notice of proposed rulemaking on qualified health claims due to the "breadth and extent of the comments requested by the agency," trade group says Jan. 13. Extension would push deadline to March 26. ANPR was published in November (1"The Tan Sheet" Dec. 1, 2003 p. 13)...

You may also be interested in...



FDA Qualified Health Claims Notice Leans Toward Ranking System

Codifying the current interim evidence-based ranking system for qualified health claims would preserve the current premarket review system already in place and bestow the most benefits, FDA states in an 1advance notice of proposed rulemaking on health claims published in the Nov. 25 Federal Register

European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake

The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.

Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start

As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.

Topics

UsernamePublicRestriction

Register

PS096479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel